NCT04413149View on ClinicalTrials.gov

Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease.

CompletedOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

April 1, 2014

Primary Completion Date

April 1, 2019

Study Completion Date

April 1, 2020

Conditions
Interstitial Lung DiseaseAnti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis
Trial Locations (1)

100730

Peking Union Medical College Hospital, Beijing

All Listed Sponsors
lead

Peking Union Medical College Hospital

OTHER

NCT04413149 - Anti-neutrophil Cytoplasmic Antibody in Interstitial Lung Disease. | Biotech Hunter | Biotech Hunter